GLP-1 receptor agonists have become one of the most talked-about treatments in weight management. But like any medical intervention, they're not for everyone. Before starting treatment, it's important to have an honest conversation with your healthcare provider about whether GLP-1 medication is appropriate for your specific situation.
Here are the key questions to ask, and what you should know before your consultation.
Am I a Candidate for GLP-1 Treatment?
GLP-1 medications are generally prescribed for adults who meet certain clinical criteria. While every provider may have slightly different guidelines, the standard benchmarks include:
It's worth noting that BMI is just one screening tool, your doctor will also consider your overall health history, family history, and individual risk factors.
Why BMI Matters (and Its Limitations)
BMI provides a quick snapshot of whether your weight falls within a range that may benefit from medical intervention. However, it doesn't account for muscle mass, bone density, or body composition. That's why a comprehensive medical evaluation is essential, not just a number on a chart.
What Are the Potential Contraindications?
Not everyone can safely take GLP-1 medications. Be sure to discuss the following with your doctor:
What Should I Expect in Terms of Results?
This is one of the most important questions, and one where realistic expectations matter.
In the STEP-1 trial (NEJM 2021), patients on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks; in SURMOUNT-1 (NEJM 2022), patients on tirzepatide 15 mg lost an average of 20.9% over 72 weeks. These trials studied the FDA-approved brand products; compounded preparations have not been studied in comparable trials, and individual results vary.
However, individual results vary significantly. Factors that influence your outcome include:
The key takeaway: GLP-1 medication is not a magic pill. It's a powerful tool that works best when combined with sustainable lifestyle changes.
What Questions Should I Bring to My Doctor?
Here's a checklist of questions to discuss during your consultation:
1. "Based on my health history, am I a good candidate for GLP-1 treatment?". Let your doctor evaluate your complete picture, not just your BMI.
2. "Are there any drug interactions I should be aware of?". If you're taking other medications (especially insulin, sulfonylureas, or blood thinners), your doctor needs to check for interactions.
3. "What's the typical dose escalation schedule?". GLP-1 medications are started at a low dose and gradually increased. Understanding the timeline helps set expectations.
4. "What side effects should I watch for?". Common side effects include nausea, constipation, and decreased appetite. Most are mild and temporary, but knowing what to expect reduces anxiety.
5. "How will my progress be monitored?". A good provider will schedule regular check-ins to track your weight, metabolic markers, and overall well-being.
6. "What happens if I stop taking the medication?". Research suggests that weight regain is possible after discontinuation. Discuss long-term planning with your provider.
7. "Is compounded semaglutide an option for me?". If cost is a barrier, ask about compounded formulations, which are prepared by state-licensed pharmacies and are not FDA-approved as final products, and may be lower-cost.
Who Should NOT Start GLP-1 Without Medical Supervision?
To be clear: GLP-1 medications should always be prescribed and monitored by a licensed healthcare provider. However, certain groups need especially careful evaluation:
How Majesta Health Can Help
Whatever provider you choose, the consultation should be conducted by a board-certified physician who evaluates your complete health profile, not an AI chatbot or automated prescribing. A real doctor reviews your case and makes a clinical determination, which may include a phone or video visit where your state's telehealth rules require one or where the physician determines it is needed.
If GLP-1 treatment is appropriate for you, we create a personalized plan that includes medication, dose management, and ongoing support. If it's not appropriate, we'll tell you honestly and suggest alternatives.
*Your health comes first. Always.*
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any medication. Individual results may vary.
<!-- related-2026-injected -->
Related 2026 guides
Frequently Asked Questions
Who is a good candidate for GLP-1 weight loss medication?
Standard FDA labeling for weight-management GLP-1s targets adults with a body mass index of 30 or higher, or 27 or higher with at least one weight-related condition such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea. Good candidates are also patients without contraindications (no personal or family history of medullary thyroid carcinoma, no multiple endocrine neoplasia syndrome type 2, no prior pancreatitis, no severe gastroparesis, not pregnant or planning pregnancy soon), and patients who are prepared to maintain the dietary and lifestyle changes that maximize results.
Who should not take GLP-1 medications?
Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, prior episodes of pancreatitis, severe gastroparesis, and pregnancy or planned pregnancy in the near term. Patients with severe kidney or gallbladder disease, active diabetic retinopathy, or who are breastfeeding should discuss risk-benefit with a physician before starting. A US-licensed physician makes the final eligibility determination after reviewing your full medical history.
What questions should I ask my doctor before starting GLP-1?
Ask: Which medication and dose are you starting me on and why? What are the expected side effects in the first 4 to 8 weeks? When and how do we escalate the dose? What signs would make us pause or stop treatment? How will we monitor for serious side effects (pancreatitis, gallbladder disease, kidney function)? What is the realistic expected weight reduction and time horizon? What is the long-term plan, including maintenance after target weight is reached? How do we handle hair shedding, fatigue, or mood changes if they happen?
Can I take GLP-1 if I don't have diabetes?
Yes, for weight management. Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved specifically for chronic weight management in non-diabetic adults who meet the BMI criteria. Compounded semaglutide and tirzepatide may also be prescribed by US-licensed physicians for weight management in non-diabetic adults at appropriate doses. Eligibility is decided by your physician based on BMI, weight-related health conditions, and overall medical history.
What if I don't qualify for GLP-1 based on BMI?
If your BMI is below 27, GLP-1 medications are generally not appropriate as a weight loss tool. Modest weight reduction is usually better pursued through nutrition, strength training, sleep optimization, and behavioral support. If your BMI is in the 25 to 27 range with a weight-related condition, a physician can review whether off-label GLP-1 prescribing is appropriate (it sometimes is, depending on clinical context). The honest answer is that GLP-1 is most beneficial for patients who meet labeled criteria and who would otherwise be unable to reach a healthy weight through lifestyle alone.
Majesta Health medical content is written against primary sources (FDA labels, peer-reviewed trials, HHS and CDC publications) and passes a documented compliance review before publication. We are rolling out named physician review with US-licensed clinicians from our partner MD Integrations (MDI): each reviewed article will show the reviewing physician's name, NPI, and review date. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across the states we currently serve through the MD Integrations Medical Services Organization (coverage varies by state; see our states page)
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited); Majesta prescriptions are dispensed through Belmar's state-licensed 503A compounding pharmacy